Shandong Boan Biotechnology Co., Ltd. Stock: price and insider trades · Hong Kong
Shandong Boan Biotechnology Co., Ltd.: what insiders have been doing
Insider filings for Shandong Boan Biotechnology Co., Ltd. are scarce in the HKEX feed, the latest one published on 29 April 2026. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 21,255 of 26,897 companies
31.4
score / 100
Value24
Quality39
FCF yld-11%
Earn yld0.4%
EV/EBITDA19.8x
ROE-4.1%
Gross mgn72%
Net mgn0.9%
Debt/EBITDA5.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$3.03
Analyst consensus
Income statement
RevenueHK$784.8M
Gross profitHK$562.4M72% margin
EBITDAHK$133.6M17% margin
Net incomeHK$7.1M-15.4% margin
Valuation
PER (trailing)392.0x
P/Book0.6x
Beta0.15
Balance sheet & cash
Market capHK$1.9B
Total debtHK$783.3M
Free Cash Flow-HK$209.2M
Debt / Equity32%
Profitability & ownership
ROE-4.1%
ROA-1.3%
% insiders66.5%
% institutions3.7%
Last declaration on 29 April 2026
Declarations1 total
- 6,800,000 sharesShareXHKGHKEX:DA20260429E00107
1 of 1 declaration
About Shandong Boan Biotechnology Co., Ltd.
Shandong Boan Biotechnology Co., Ltd. is a company focused on the development and manufacturing of biopharmaceutical products. It is listed on the Hong Kong Stock Exchange, XHKG.
